These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6620828)

  • 1. [Effect of antibradykinin preparations and nicotinic acid on the microcirculation and blood oxygen balance of ischemic heart disease patients in the initial stage of heart failure].
    Denisiuk VI
    Kardiologiia; 1983 Aug; 23(8):103-5. PubMed ID: 6620828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
    Kats GL; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Mal'tseva NV
    Vrach Delo; 1989 Sep; (9):16-9. PubMed ID: 2609611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of tocopherol and nicotinic acid on the microcirculation and blood coagulability in patients with ischemic heart disease].
    Chernomorets NN; Kotlubeĭ GV; Vatutin NT; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Lobach EIa; Mal'tseva NV; Mitrofanov AN
    Vrach Delo; 1990 Dec; (12):6-8. PubMed ID: 2089804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of papaverine and cholinolytics on the function of the hepatobiliary system in patients with cholecystitis associated with chronic ischemic heart disease].
    Kushnir VE; Novopashennaia VV; Sidorova LL; Kuklia IuI
    Vrach Delo; 1987 Dec; (12):19-22. PubMed ID: 3445559
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of microcirculatory hemodynamics, blood oxygen balance and carbohydrate metabolism in the pathogenesis of the initial (preclinical) stage of heart failure in ischemic heart disease].
    Denisiuk VI
    Ter Arkh; 1985; 57(1):46-9. PubMed ID: 3983843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrocyte acid resistance in the drug treatment of heart failure in patients with ischemic heart disease].
    Sakharchuk II; Starodub NF; Sisetskiĭ AP; Artiukh VP; Denisenko GT
    Vrach Delo; 1991 May; (5):33-5. PubMed ID: 1866910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Variants of chronic heart failure in ischemic heart disease patients and optimization of their treatment].
    Bala IuM; Babenko NI
    Kardiologiia; 1987 Dec; 27(12):51-5. PubMed ID: 3327994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G; Melina D
    Clin Ter; 1980 Mar; 92(5):533-47. PubMed ID: 7449327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of korinfar in the early stages of heart failure in ischemic heart disease].
    Goncharova LN; Danilova IV
    Sov Med; 1987; (12):85-8. PubMed ID: 3445181
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chorionic gonadotropin in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Bondarenko IP
    Vrach Delo; 1984 Jul; (7):75-8. PubMed ID: 6475028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].
    Volkov VS; Bratoliubov VP
    Kardiologiia; 1984 Aug; 24(8):89-92. PubMed ID: 6436573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
    Sakharchuk II; Denisenko GT; Grushko VS; Bodaretskaia OI; Pishchalenko AN
    Vrach Delo; 1989 Sep; (9):21-3. PubMed ID: 2609613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficiency of carbocromen in coronary heart disease--an application problem?].
    Rupprecht E
    ZFA (Stuttgart); 1977 Jun; 53(17):1010-4. PubMed ID: 329600
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical management of heart failure secondary to coronary artery disease.
    Challapalli S; Bonow RO; Gheorghiade M
    Coron Artery Dis; 1998; 9(10):659-74. PubMed ID: 9894618
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary prevention of ischemic heart disease].
    Khamidov NKh; Dodobaeva MS
    Klin Med (Mosk); 1991 Jan; 69(1):61-3. PubMed ID: 2023397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pyridinolcarbamate (parmidine) on some bradykinin effects].
    Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(2):176-9. PubMed ID: 1278349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.